Jan 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of 2025, more than double what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results